Treatment with granulocyte-macrophage colony-stimulating factor is associated with reduced indoleamine 2,3-dioxygenase activity and kynurenine pathway catabolites in patients with severe sepsis and septic shock. (Q43230804)
Jump to navigation
Jump to search
scientific article published in March 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | Treatment with granulocyte-macrophage colony-stimulating factor is associated with reduced indoleamine 2,3-dioxygenase activity and kynurenine pathway catabolites in patients with severe sepsis and septic shock. |
scientific article published in March 2010 |
Statements
Treatment with granulocyte-macrophage colony-stimulating factor is associated with reduced indoleamine 2,3-dioxygenase activity and kynurenine pathway catabolites in patients with severe sepsis and septic shock (English)
Jan-Philip Zeden
Rene Pschowski
Ben Hammoud
Christina Fotopoulou
Dietrich Hasper
Gerhard Fusch
Stephan Von Haehling
Christian Meisel
Christine Schütt
1 March 2010
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference